pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4476 |
Genomic Coordinates | chr9: 36893462 - 36893531 |
Description | Homo sapiens miR-4476 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4476 | ||||||||||||||||||||||||||||
Sequence | 45| CAGGAAGGAUUUAGGGACAGGC |66 | ||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||
Experiments | Illumina | ||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | CNNM4 | ||||||||||||||||||||
Synonyms | ACDP4 | ||||||||||||||||||||
Description | cyclin and CBS domain divalent metal cation transport mediator 4 | ||||||||||||||||||||
Transcript | NM_020184 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on CNNM4 | |||||||||||||||||||||
3'UTR of CNNM4 (miRNA target sites are highlighted) |
>CNNM4|NM_020184|3'UTR 1 CAGGAGGGCCCGGGGCCCCCTGCCCACCCTGCGGGGGCCTCCCCAGTGGGCCCACATGAAGAGAGGGAACCTGTTAGTCC 81 AGAAAGGATACGGATAGATAGCCTGTCTGACTGAACAGCCAGATGGCCCCCAGCCTATGGGGGATCTGGCCTCTGCCAGG 161 GACCTCTGAGTAGCTCTGAGGTGGCACTGTCCAGCCCTGGATAGGGGGGGCAGTGGGCCAGCTACCGTAAGCAAAGGCTG 241 TTTTTTACTGAGAGAATTTCTAAAGTAGGCTCATCACTTTTTTTTAAATATCATTTTGGGAAGGGAAGACAGGGTTAAGG 321 AACTTTATTTAAAAAAAAAATATTTTTTTCCTAAAAACTATAAAAGAGGAAGGGTTTCTTGTCCCGGGAAGCAACGGACA 401 TAATCTGTTCCCAGCCATGGCCTTCCAGCTTGTGTCCCTGATTCAGGGAGCTCTCCCTTCCTCCTCCTCCTCCTCCTCCG 481 GAGGTGGGATCCCAGAGCCTGCCAGTGGAGGCTTATCTGTTGGGAGGAAGACAGCTCTTCACAGAAGCAAAGAACAAAAT 561 GGCATGGAGATCAGCTGCCTGAGCACCTGCGCTGTAGCTTATCTGACAACGCTGAGGCCACGAGCTCCTGGGTAGCTGTG 641 ATCAGGGACATGATAATCTGAGCTATGCAGAGGAGCACATCTGTTGTCAACTGCTGTACCCAGAAATCTAGAACTCTGCC 721 GACAGCCTCTCCTGGTGAGTCGGGACTCAGCTGAGGACACATCCCCACCCTGCCTCCCATCTGGCCCTTTGGACAACTGG 801 CCCTTTGTGACAGGGCTGACTCAAGTGTTAGGCAGGGTCTCAGGCCTTTGATTGCTCACCCCTGCTCCCCAGGCCCTGCC 881 CTCACTTTTACCAAAGGTTCTCCCTCGGCGGGAGGGCATCTGTGTTGGAGGTGATTTGTCTGGGTTCTTCCTTTTGGTTC 961 CAGAAGGAACTGTCAGTCATCAGCATCTGCGTTGTTAGCAGTCAGTACCACCCCCGCCCCACAATGACAGTCAAGGCTGA 1041 CTTGTTGACTGAAGCCTTTTTCCCAGACCCCTTATTTCGAATCCCCAAGCTTCAGTCCCTCTTGGGGGTGGAGACAAGAG 1121 GACATGTGGGAAGCCACGGAAGCAGGTTCTTTATGTCCTCTCCTCTGTGGCTGGCAAGGCTCACCTGGCCTTATCCACCC 1201 ACTTATGGAACCTCAGGAGAGGAGGGCTCCTCCTAAAGGCATGCAGCTTGCAGCCCCTCTTTCTCACACGTGTGATCCTA 1281 GCGTGAGAGGTCATCCTGCCCTTGCTGAAGTTAGTAGTACTGTACTAAGAGCTCTGCCCTCATGTGAATTCCTGCCCTGG 1361 CGCCTCTTCCCTGGGGCTGAATCAGGCCCTGCTGCAAAACTCCAGGCTTCCCAGGGTTGGGGAGGCTGTGGGACCAAGGT 1441 CCATGTTGGTCCTTCCACTGGGTGCAGCAGGAGCTGGGTCCCGAGAGCCTGGCAGGTGAAACTCTGCAGGCCTTCCGCCT 1521 GATTATTATTTATTCACTCCTTTCCTCACCCCAAGTGCCCTGCTCTCCAGGTGCCTAGAGTATCCTAACTCTTAGGACCA 1601 GGGATTGTCTTGCACCAAGTATGCCTACCCCTGGCCAGTCTGAGGTCTCCTAGCCATAGAACTGACTCCTGGAAGCCTGG 1681 AGAGAAGGTGGTGACACCCATGGGTTCTCAACTGTAAGGAAAAAAGACACCAGACTTTTGTTCCCTAGTGGGGGAAAGCC 1761 CTTAGTCTTGTACAGGAGCAGCTTGCTCCCAAGTCCTTTTGGAAGCTGGCAGAGCTATATTCCTGACAGCCCTGACTGCC 1841 AGGTAGAGCAAAAGACATTGGTGGGGGTATGTGAAGCAAAAGGGGCAGGTGCACACACCTCCACAGTGACCTCTGTGCAC 1921 ACGGTTACCACCAACTGGCTGGCCCTCCTCCTCTTCCCTGGCCCATTGATCATCCCTTCTCACAGAGGGTCATCATTATT 2001 TCCAAATATTGTTTGTCTGATGACTTCCTCTTCCCAGTGCAATTTTTCCCTTCCTATTTCAACCTCTGGTTCCTGGGATG 2081 AGCCATACCCTGGAACTGGCCCACCCACTGTGTCTTCCACGTAAGGGAGACCTTTGCAAAGGGCATCCAAATGGGTAGGC 2161 AGGTGACAGCCGCCGTATTTATTTTGCATAATATTTTAATTTGTATATTTTTGTGATTTATTTTGGCGTTATGAGTTTGA 2241 CTCTCGGGGAGTTTTGTTGTTATGACTCTTGTGTCTTTTGTCACAAAACAATGATATTTGCTAAACGATATATGGAATTT 2321 ATTTTTGATTGGTAATAAAAAATCAAATATGTATAAATCCTGGTGAATCTACAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545212. RNA binding protein: AGO1. Condition:Control
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 26504.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714645. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | C8166 , TZM-bl |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462572. RNA binding protein: AGO2. Condition:C8166 NL4-3
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM545212 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000540067.1 | 3UTR | UCCUCCUCCUCCUCCUCC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM714645 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repB |
Location of target site | ENST00000540067.1 | 3UTR | CAAUUUUUCCCUUCCUAUUUCAACCUCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM1462572 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | C8166 / C8166 NL4-3 |
Location of target site | ENST00000540067.1 | 3UTR | CCUUCCUCCUCCUCCUCCUCCUCCGG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000540067.1 | 3UTR | CCUUCCUCCUCCUCCUCCUCCUCCGGAGGUGGGAUCCC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
152 hsa-miR-4476 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT065631 | CLIC4 | chloride intracellular channel 4 | 2 | 2 | ||||||||
MIRT076187 | GID4 | GID complex subunit 4 homolog | 2 | 4 | ||||||||
MIRT086304 | HOXD8 | homeobox D8 | 2 | 6 | ||||||||
MIRT110644 | ARID5B | AT-rich interaction domain 5B | 2 | 2 | ||||||||
MIRT144337 | NFAT5 | nuclear factor of activated T-cells 5 | 2 | 2 | ||||||||
MIRT196634 | TAOK1 | TAO kinase 1 | 2 | 6 | ||||||||
MIRT227655 | SET | SET nuclear proto-oncogene | 2 | 2 | ||||||||
MIRT263546 | PPIF | peptidylprolyl isomerase F | 2 | 4 | ||||||||
MIRT266189 | TXNIP | thioredoxin interacting protein | 2 | 4 | ||||||||
MIRT266815 | SLC25A44 | solute carrier family 25 member 44 | 2 | 2 | ||||||||
MIRT285538 | CDT1 | chromatin licensing and DNA replication factor 1 | 2 | 2 | ||||||||
MIRT295094 | PTBP1 | polypyrimidine tract binding protein 1 | 2 | 2 | ||||||||
MIRT300906 | KREMEN1 | kringle containing transmembrane protein 1 | 2 | 2 | ||||||||
MIRT304110 | CNNM4 | cyclin and CBS domain divalent metal cation transport mediator 4 | 2 | 6 | ||||||||
MIRT314891 | RGMB | repulsive guidance molecule family member b | 2 | 2 | ||||||||
MIRT364225 | ANP32B | acidic nuclear phosphoprotein 32 family member B | 2 | 2 | ||||||||
MIRT366237 | VMA21 | VMA21, vacuolar ATPase assembly factor | 2 | 2 | ||||||||
MIRT405440 | RAB5B | RAB5B, member RAS oncogene family | 2 | 2 | ||||||||
MIRT443613 | OR2D2 | olfactory receptor family 2 subfamily D member 2 | 2 | 2 | ||||||||
MIRT445947 | SCML4 | Scm polycomb group protein like 4 | 2 | 2 | ||||||||
MIRT445957 | MLLT11 | MLLT11, transcription factor 7 cofactor | 2 | 2 | ||||||||
MIRT445970 | IKZF5 | IKAROS family zinc finger 5 | 2 | 2 | ||||||||
MIRT448066 | MMP15 | matrix metallopeptidase 15 | 2 | 2 | ||||||||
MIRT449498 | ZBTB4 | zinc finger and BTB domain containing 4 | 2 | 2 | ||||||||
MIRT450831 | IFFO1 | intermediate filament family orphan 1 | 2 | 2 | ||||||||
MIRT451270 | NDUFA11 | NADH:ubiquinone oxidoreductase subunit A11 | 2 | 2 | ||||||||
MIRT451318 | LGALS3BP | galectin 3 binding protein | 2 | 2 | ||||||||
MIRT451403 | FARSA | phenylalanyl-tRNA synthetase alpha subunit | 2 | 2 | ||||||||
MIRT451941 | TMPRSS5 | transmembrane protease, serine 5 | 2 | 2 | ||||||||
MIRT452028 | NLRP6 | NLR family pyrin domain containing 6 | 2 | 2 | ||||||||
MIRT452503 | HMGXB3 | HMG-box containing 3 | 2 | 2 | ||||||||
MIRT453852 | SDK1 | sidekick cell adhesion molecule 1 | 2 | 2 | ||||||||
MIRT454523 | ZFYVE27 | zinc finger FYVE-type containing 27 | 2 | 2 | ||||||||
MIRT455402 | PLA2G2F | phospholipase A2 group IIF | 2 | 2 | ||||||||
MIRT455442 | ID3 | inhibitor of DNA binding 3, HLH protein | 2 | 2 | ||||||||
MIRT456983 | MANEA | mannosidase endo-alpha | 2 | 2 | ||||||||
MIRT457610 | IDS | iduronate 2-sulfatase | 2 | 2 | ||||||||
MIRT458319 | TNFAIP8L3 | TNF alpha induced protein 8 like 3 | 2 | 2 | ||||||||
MIRT458756 | CES2 | carboxylesterase 2 | 2 | 2 | ||||||||
MIRT458960 | SAMD4B | sterile alpha motif domain containing 4B | 2 | 2 | ||||||||
MIRT460403 | GPHA2 | glycoprotein hormone alpha 2 | 2 | 2 | ||||||||
MIRT460632 | IGFBP4 | insulin like growth factor binding protein 4 | 2 | 2 | ||||||||
MIRT461760 | DDX11 | DEAD/H-box helicase 11 | 2 | 2 | ||||||||
MIRT461924 | NECAB3 | N-terminal EF-hand calcium binding protein 3 | 2 | 2 | ||||||||
MIRT461977 | PACSIN1 | protein kinase C and casein kinase substrate in neurons 1 | 2 | 2 | ||||||||
MIRT462271 | TPI1 | triosephosphate isomerase 1 | 2 | 2 | ||||||||
MIRT462304 | PPM1H | protein phosphatase, Mg2+/Mn2+ dependent 1H | 2 | 2 | ||||||||
MIRT462725 | SEMA4G | semaphorin 4G | 2 | 2 | ||||||||
MIRT463414 | ZC3HAV1L | zinc finger CCCH-type containing, antiviral 1 like | 2 | 2 | ||||||||
MIRT463525 | ZBTB7B | zinc finger and BTB domain containing 7B | 2 | 2 | ||||||||
MIRT464089 | VPS4A | vacuolar protein sorting 4 homolog A | 2 | 2 | ||||||||
MIRT464623 | UBE4B | ubiquitination factor E4B | 2 | 2 | ||||||||
MIRT465030 | LINC00598 | long intergenic non-protein coding RNA 598 | 2 | 2 | ||||||||
MIRT465562 | TOB2 | transducer of ERBB2, 2 | 2 | 2 | ||||||||
MIRT465890 | TMEM43 | transmembrane protein 43 | 2 | 2 | ||||||||
MIRT466428 | TFAP2A | transcription factor AP-2 alpha | 2 | 8 | ||||||||
MIRT466593 | TBC1D2B | TBC1 domain family member 2B | 2 | 2 | ||||||||
MIRT467623 | SLC7A5 | solute carrier family 7 member 5 | 2 | 2 | ||||||||
MIRT468511 | SESN2 | sestrin 2 | 2 | 2 | ||||||||
MIRT468649 | SEH1L | SEH1 like nucleoporin | 2 | 2 | ||||||||
MIRT468737 | SDC4 | syndecan 4 | 2 | 2 | ||||||||
MIRT468752 | SDC2 | syndecan 2 | 2 | 2 | ||||||||
MIRT469182 | RNF111 | ring finger protein 111 | 2 | 2 | ||||||||
MIRT469476 | REEP5 | receptor accessory protein 5 | 2 | 2 | ||||||||
MIRT472078 | NOVA2 | NOVA alternative splicing regulator 2 | 2 | 2 | ||||||||
MIRT472093 | NOLC1 | nucleolar and coiled-body phosphoprotein 1 | 2 | 2 | ||||||||
MIRT472194 | NHP2L1 | small nuclear ribonucleoprotein 13 | 2 | 2 | ||||||||
MIRT472453 | NAV2 | neuron navigator 2 | 2 | 6 | ||||||||
MIRT474493 | KLHDC8B | kelch domain containing 8B | 2 | 2 | ||||||||
MIRT475174 | IP6K1 | inositol hexakisphosphate kinase 1 | 2 | 2 | ||||||||
MIRT475350 | IFNLR1 | interferon lambda receptor 1 | 2 | 2 | ||||||||
MIRT476474 | GATAD2B | GATA zinc finger domain containing 2B | 2 | 2 | ||||||||
MIRT477094 | FAM168A | family with sequence similarity 168 member A | 2 | 2 | ||||||||
MIRT477179 | F3 | coagulation factor III, tissue factor | 2 | 6 | ||||||||
MIRT478026 | DNAJC8 | DnaJ heat shock protein family (Hsp40) member C8 | 2 | 2 | ||||||||
MIRT479587 | CDC42SE1 | CDC42 small effector 1 | 2 | 2 | ||||||||
MIRT480117 | CALR | calreticulin | 2 | 2 | ||||||||
MIRT480465 | C11orf84 | chromosome 11 open reading frame 84 | 2 | 2 | ||||||||
MIRT480803 | BLOC1S2 | biogenesis of lysosomal organelles complex 1 subunit 2 | 2 | 6 | ||||||||
MIRT481076 | B4GALT1 | beta-1,4-galactosyltransferase 1 | 2 | 2 | ||||||||
MIRT482576 | ABHD2 | abhydrolase domain containing 2 | 2 | 2 | ||||||||
MIRT482690 | NXN | nucleoredoxin | 2 | 4 | ||||||||
MIRT483599 | SLC26A9 | solute carrier family 26 member 9 | 2 | 2 | ||||||||
MIRT485011 | TNRC6B | trinucleotide repeat containing 6B | 2 | 4 | ||||||||
MIRT488051 | PABPC1L2B | poly(A) binding protein cytoplasmic 1 like 2B | 2 | 2 | ||||||||
MIRT488067 | PABPC1L2A | poly(A) binding protein cytoplasmic 1 like 2A | 2 | 2 | ||||||||
MIRT488176 | PRRC2B | proline rich coiled-coil 2B | 2 | 4 | ||||||||
MIRT488859 | UBTF | upstream binding transcription factor, RNA polymerase I | 2 | 2 | ||||||||
MIRT489074 | STARD3 | StAR related lipid transfer domain containing 3 | 2 | 2 | ||||||||
MIRT489181 | ANKRD45 | ankyrin repeat domain 45 | 2 | 2 | ||||||||
MIRT489981 | DDB1 | damage specific DNA binding protein 1 | 2 | 2 | ||||||||
MIRT490225 | WRN | Werner syndrome RecQ like helicase | 2 | 2 | ||||||||
MIRT491084 | HILPDA | hypoxia inducible lipid droplet associated | 2 | 2 | ||||||||
MIRT491540 | HDAC5 | histone deacetylase 5 | 2 | 2 | ||||||||
MIRT492540 | PSMD11 | proteasome 26S subunit, non-ATPase 11 | 2 | 2 | ||||||||
MIRT499034 | MAG | myelin associated glycoprotein | 2 | 2 | ||||||||
MIRT499420 | PLCG2 | phospholipase C gamma 2 | 2 | 4 | ||||||||
MIRT499820 | LONRF3 | LON peptidase N-terminal domain and ring finger 3 | 2 | 2 | ||||||||
MIRT500046 | SDE2 | SDE2 telomere maintenance homolog | 2 | 6 | ||||||||
MIRT500844 | SYPL1 | synaptophysin like 1 | 2 | 4 | ||||||||
MIRT504518 | PPP1R9B | protein phosphatase 1 regulatory subunit 9B | 2 | 2 | ||||||||
MIRT505622 | SLC25A37 | solute carrier family 25 member 37 | 2 | 2 | ||||||||
MIRT509134 | STK4 | serine/threonine kinase 4 | 2 | 2 | ||||||||
MIRT509219 | BUB3 | BUB3, mitotic checkpoint protein | 2 | 4 | ||||||||
MIRT510752 | SLC7A1 | solute carrier family 7 member 1 | 2 | 2 | ||||||||
MIRT512115 | CREBZF | CREB/ATF bZIP transcription factor | 2 | 2 | ||||||||
MIRT512317 | ACTR2 | ARP2 actin related protein 2 homolog | 2 | 6 | ||||||||
MIRT517395 | BGN | biglycan | 2 | 4 | ||||||||
MIRT518412 | SSU72 | SSU72 homolog, RNA polymerase II CTD phosphatase | 2 | 4 | ||||||||
MIRT521362 | RPL35A | ribosomal protein L35a | 2 | 2 | ||||||||
MIRT525072 | FRK | fyn related Src family tyrosine kinase | 2 | 2 | ||||||||
MIRT525800 | SOD2 | superoxide dismutase 2 | 2 | 2 | ||||||||
MIRT530430 | SULT1B1 | sulfotransferase family 1B member 1 | 2 | 2 | ||||||||
MIRT541467 | AURKA | aurora kinase A | 2 | 2 | ||||||||
MIRT544303 | TSPYL1 | TSPY like 1 | 2 | 2 | ||||||||
MIRT546415 | SPRED3 | sprouty related EVH1 domain containing 3 | 2 | 2 | ||||||||
MIRT546582 | SAR1A | secretion associated Ras related GTPase 1A | 2 | 2 | ||||||||
MIRT548764 | CNN3 | calponin 3 | 2 | 2 | ||||||||
MIRT549809 | KIAA0391 | KIAA0391 | 2 | 2 | ||||||||
MIRT550611 | MTHFR | methylenetetrahydrofolate reductase | 2 | 2 | ||||||||
MIRT552227 | FIG4 | FIG4 phosphoinositide 5-phosphatase | 2 | 4 | ||||||||
MIRT554008 | SPTLC1 | serine palmitoyltransferase long chain base subunit 1 | 2 | 2 | ||||||||
MIRT554116 | SMARCE1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 | 2 | 2 | ||||||||
MIRT555100 | PURB | purine rich element binding protein B | 2 | 2 | ||||||||
MIRT560290 | HRH2 | histamine receptor H2 | 2 | 2 | ||||||||
MIRT560381 | TIMM8A | translocase of inner mitochondrial membrane 8A | 2 | 2 | ||||||||
MIRT560800 | EPM2AIP1 | EPM2A interacting protein 1 | 2 | 2 | ||||||||
MIRT560978 | IWS1 | IWS1, SUPT6H interacting protein | 2 | 2 | ||||||||
MIRT561161 | BCL2L12 | BCL2 like 12 | 2 | 2 | ||||||||
MIRT562389 | EN2 | engrailed homeobox 2 | 2 | 2 | ||||||||
MIRT562482 | CHORDC1 | cysteine and histidine rich domain containing 1 | 2 | 2 | ||||||||
MIRT567784 | DGAT2 | diacylglycerol O-acyltransferase 2 | 2 | 2 | ||||||||
MIRT568831 | TRIM67 | tripartite motif containing 67 | 2 | 2 | ||||||||
MIRT569555 | UNC119B | unc-119 lipid binding chaperone B | 2 | 2 | ||||||||
MIRT572382 | ATOX1 | antioxidant 1 copper chaperone | 2 | 2 | ||||||||
MIRT575792 | Tnfrsf10b | tumor necrosis factor receptor superfamily, member 10b | 2 | 2 | ||||||||
MIRT610505 | CTBS | chitobiase | 2 | 4 | ||||||||
MIRT616605 | PAPD5 | poly(A) RNA polymerase D5, non-canonical | 2 | 2 | ||||||||
MIRT621780 | TMEM87B | transmembrane protein 87B | 2 | 2 | ||||||||
MIRT634217 | TMEM192 | transmembrane protein 192 | 2 | 2 | ||||||||
MIRT639651 | WHAMM | WAS protein homolog associated with actin, golgi membranes and microtubules | 2 | 2 | ||||||||
MIRT642500 | ALDOA | aldolase, fructose-bisphosphate A | 2 | 2 | ||||||||
MIRT643217 | TYW3 | tRNA-yW synthesizing protein 3 homolog | 2 | 4 | ||||||||
MIRT674822 | KCNJ10 | potassium voltage-gated channel subfamily J member 10 | 2 | 2 | ||||||||
MIRT697356 | ZNF426 | zinc finger protein 426 | 2 | 2 | ||||||||
MIRT704675 | CHTOP | chromatin target of PRMT1 | 2 | 2 | ||||||||
MIRT708704 | TFDP2 | transcription factor Dp-2 | 2 | 2 | ||||||||
MIRT709660 | DFFB | DNA fragmentation factor subunit beta | 2 | 2 | ||||||||
MIRT711280 | SDR9C7 | short chain dehydrogenase/reductase family 9C member 7 | 2 | 2 | ||||||||
MIRT713733 | SUCO | SUN domain containing ossification factor | 2 | 2 | ||||||||
MIRT715006 | TSPAN11 | tetraspanin 11 | 2 | 2 | ||||||||
MIRT718400 | ALDH1A3 | aldehyde dehydrogenase 1 family member A3 | 2 | 2 |
miRNA-Drug Associations | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|